A review of clozapine safety.

Expert Opin Drug Saf

Department of Clinical and Biomedical Sciences, Barwon Health, Swanston Centre, University of Melbourne, PO Box 281, Geelong, Victoria 3220, Australia.

Published: July 2005

Clozapine is a distinctive antipsychotic agent, having a unique clinical profile and an idiosyncratic safety profile. More so than with other agents, the weighting of its adverse event profile is critical, in order to counterbalance its clear clinical advantages. The safety issues with clozapine are in a number of areas, some of which are considered medical emergencies and potentially life-threatening. These include haematological (neutropenia and agranulocytosis), CNS (seizures), cardiovascular (myocarditis and cardiomyopathy), metabolic (diabetes), gastrointestinal and neuromuscular. Understanding the safety profile of clozapine allows an informed use of the agent that can maximise its clear clinical benefit and minimise the known risks.

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.4.4.731DOI Listing

Publication Analysis

Top Keywords

safety profile
8
clear clinical
8
review clozapine
4
safety
4
clozapine safety
4
safety clozapine
4
clozapine distinctive
4
distinctive antipsychotic
4
antipsychotic agent
4
agent unique
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!